In the wake of the Obamacare�fiasco, small cap healthcare information systems stock Computer Programs & Systems, Inc (NASDAQ: CPSI) has put in a good performance, meaning its worth taking a closer look at the stock along with the performance of large cap players like Cerner Corporation (NASDAQ: CERN) and McKesson Corporation (NYSE: MCK) and small cap Quality Systems, Inc (NASDAQ: QSII).
What is Computer Programs & Systems, Inc?Founded in 1979 and headquartered in Mobile, Alabama, small cap Computer Programs & Systems is a�leading provider of electronic health record (EHR) systems to rural, community and critical access hospitals and has implemented its comprehensive EHR System to more than 650 community and rural hospitals across the nation. Last year, Computer Programs & Systems expanded with the launch of TruBridge, a company devoted entirely to services for the business office, consulting and managed IT needs of community healthcare providers. Otherwise, Computer Programs & Systems is organized into five major divisions: Information Technology Services, Software Support Services, Product Development Services, Administration and Sales.
Top 10 Consumer Service Companies To Own In Right Now: Telefonica SA(TEF)
Telefonica, S.A. provides fixed and mobile telephony services primarily in Spain, rest of Europe, and Latin America. Its fixed telecommunication services include PSTN lines; ISDN accesses; public telephone; local, domestic, and international long distance and fixed-to-mobile communications; corporate communications; video telephony; supplementary and business-oriented value-added services; network services; leasing and sale of handset equipment; and telephony information services. The company?s Internet and broadband multimedia services comprise Internet service provider service; portal and network services; retail and wholesale broadband access; narrowband switched access to Internet; naked ADSL, a broadband connection; residential-oriented value-added services; companies-oriented value-added services; television services, such as IPTV, cable television, and satellite television; and Fiber to the Home, a service for high speed Internet access and digital video recording. Its data and business-solutions services principally include leased lines; virtual private network services; fiber optics services; the provision of hosting and application; outsourcing and consultancy services; desktop services; and system integration and professional services. The company?s wholesale services for telecommunication operators primarily comprise domestic interconnection services; international wholesale services; leased lines for other operators? network deployment; local loop leasing under the unbundled local loop regulation framework; and bit stream services. It also offers various mobile and related services and products that include mobile voice services, value added services, mobile data and Internet services, wholesale services, corporate services, roaming, fixed wireless, and trunking and paging services. The company has a strategic alliance with China Unicom (Hong Kong) Limited. Telefonica, S.A. was founded in 1924 and is headquartered in Madrid, Spai n.
Advisors' Opinion:- [By Jayson Derrick]
Telefonica (NYSE: TEF) announced it is in talks to acquire an un-named Mexican rival for as much as 3 billion euros. Shares gained 1.22 percent, closing at $16.63.
Top Net Payout Yield Stocks To Own For 2014: Oplink Communications Inc.(OPLK)
Oplink Communications, Inc., together with its subsidiaries, designs, manufactures, and sells optical networking components and subsystems worldwide. The company?s products are used to expand optical bandwidth, amplify optical signals, monitor and protect wavelength performance, redirect light signals, ensure signal connectivity, and provide signal transmission and reception within an optical network. It offers bandwidth creation products, such as wavelength expansion products comprising dense wavelength division multiplexers (DWDM), coarse wavelength division multiplexers, band wavelength division multiplexers, and DWDM interleavers; and optical amplification products consisting of gain blocks, erbium doped fiber amplifiers, wavelength division multiplexers pump/signal combiners, integrated hybrid components, WDM pump combiners, polarization beam combiners, gain flattening filters isolators, isolators, and tap couplers. The company also offers bandwidth management produc ts, such as optical switching and routing products comprising optical add/drop multiplexers, wavelength selective switches, reconfigurable OADMs, switches, and circulators; wavelength conditioning products that include variable optical attenuators, variable multiplexers, and dynamic band equalization products; and wavelength performance monitoring and protection products consisting of supervisory channel WDM, integrated WDM and tap monitor arrays, optical channel monitors, and wavelength protection subsystems. In addition, it provides optical interconnect products, including connectors and adapters, fixed attenuators, patchcords, and termination and distribution enclosures; and transmission products, such as small form-factor pluggable transceivers, XFP transceivers, CWDM transceivers, bi-directional transceivers, DWDM transceivers, optical supervisory channel transceivers, GEPON products, and 40G/100G transceiver products. The company was founded in 1995 and is headquartere d in Fremont, California.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Oplink Communications (Nasdaq: OPLK ) , whose recent revenue and earnings are plotted below. - [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Oplink Communications (Nasdaq: OPLK ) , whose recent revenue and earnings are plotted below.
Top Net Payout Yield Stocks To Own For 2014: diaDexus, Inc. (DDXS)
diaDexus, Inc. (diaDexus), incorporated on November 27, 1995, is a medical diagnostics company. The Company is focused on the development and commercialization of in vitro diagnostic products addressing unmet needs in cardiovascular disease. diaDexus�� product, the PLAC Test, helps identify individuals suffering a heart attack or stroke, the #1 and #3 causes of death, respectively in the United States. The PLAC Test measures Lp-PLA2, which is a vascular-specific inflammatory marker implicated in the formation of rupture-prone plaque.
GlaxoSmithKline (GSK) has developed an Lp-PLA2 inhibitor (darapladib) and is testing the drug in two large, global, Phase III clinical trials involving over 27,000 patients to determine if inhibition of the enzyme reduces cardiovascular events. The PLAC Test is a blood test, available nationally through clinical reference, hospital, and advanced cardiovascular diagnostic laboratories.
Advisors' Opinion:- [By Peter Graham]
Small cap stocks Pulse Network Inc (OTCBB: TPNI), Sterling Consolidated Corp (OTCBB: STCC) and diaDexus, Inc (OTCMKTS: DDXS) have or could start to sizzle for investors. However, I should also mention that two of these stocks have been the subject of paid promotions while a third apparently has not been, and could be the real deal. With that in mind, here is a closer look along with a quick reality check about all three small caps to help you decide whether they are hot or not:
- [By Peter Graham]
Small cap medical device or biotech related stocks Therapeutic Solutions International Inc (OTCMKTS: TSOI), diaDexus, Inc (OTCMKTS: DDXS) and Spherix Inc (NASDAQ: SPEX) have been getting some attention lately in various investment newsletters with the good news being that it appears none are the subject of paid promotions from stock promoters. So why are these three stocks all of a sudden getting some attention and what else do you need to know about them before you make a short or a long term bet on one? Here is a closer look at the whole picture and what you might be missing:
Top Net Payout Yield Stocks To Own For 2014: Astronics Corporation(ATRO)
Astronics Corporation, through its subsidiaries, designs and manufactures products for the aerospace and defense industries worldwide. It operates in two segments, Aerospace and Test Systems. The Aerospace segment?s product lines include aircraft lighting, cabin electronics, airframe power, avionics databus products, and airfield lighting. This segment serves airframe manufacturers that build aircraft for the commercial, military, and general aviation markets; suppliers; and aircraft operators, such as airlines and branches of the U.S. Department of Defense, as well as the Federal Aviation Administration and airport operators. The Test Systems segment designs, develops, manufactures, and maintains communications and weapons test systems, and training and simulation devices for military applications. It sells its products primarily to the U.S. military, foreign militaries, and manufacturers of military communication systems. The company was founded in 1968 and is headquart ered in East Aurora, New York.
Advisors' Opinion:- [By Jeremy Bowman]
What: Shares of Astronics Corporation (NASDAQ: ATRO ) were headed for the stars today, gaining 11% after a strong quarterly earnings report.
Top Net Payout Yield Stocks To Own For 2014: Awilco Drilling PLC (AWLCF)
Awilco Drilling PLC is a United Kingdom-based drilling contractor. The Company�� principal business is to own offshore drilling rigs for use in offshore drilling for oil and gas, and to provide drilling services for oil and gas companies using these rigs. The Company operates two semi-submersible drilling rigs: WilHunter, previously Arctic IV and WilPhoenix, previously Arctic II. As of December 31, 2011, the Company wholly owned five subsidiaries, namely WilPhoenix (UK) Ltd, WilHunter (UK) Ltd, WilPhoenix (Malta) Ltd, WilHunter (Malta) Ltd and the Singapore-based Awilco Drilling Pte Ltd. As of December 31, 2011, Awilco Drilling AS was the Company's largest shareholder and controlled 49% shares. Advisors' Opinion:- [By Ben Levisohn]
We expect Caledonia to generate close to $600M in EBITDA. While RIGs mid-water OPEX has averaged about $125k/d we expect it to be lower at Caledonia. 2015 Consensus EBITDA for RIG is ~$3B which means 20% of RIGs 2015 EBITDA comes from the rigs that will become Caledonia. The problem (in a bear market) is that companies with lower end rigs trade at a discount ��just ask Awilco (AWLCF), Fred Olsen Energy, and Paragon Offshore (PGN) which trade at an average multiple of 3.3x on 2015 EBITDA versus RIG which trades at 6.3x.
Top Net Payout Yield Stocks To Own For 2014: ArQule Inc.(ARQL)
ArQule, Inc., a clinical-stage biotechnology company, engages in the research and development of cancer therapeutics directed toward molecular targets and biological processes. Its lead product ARQ 197 is non-adenosine triphosphate competitive inhibitor of the c-Met receptor tyrosine kinase, which is being evaluated as monotherapy and in combination therapy in a Phase II clinical development program that includes trials in non-small cell lung cancer, c-Met-associated soft tissue sarcomas, pancreatic adenocarcinoma, hepatocellular carcinoma, germ cell tumors, and colorectal cancer. The company is also developing ARQ 621, a Phase I program focused on inhibition of the Eg5 kinesin spindle protein. Its clinical stage products include ARQ 501, ARQ 761, and ARQ 171, which are designed to kill cancer cells selectively while sparing normal cells through the direct activation of DNA damage response/checkpoint pathways. In addition, the company involves in pre-clinical development o f B-RAF and AKIP Kinase inhibitors. The company has collaborations with Kyowa Hakko Kirin Co., Ltd. and Daiichi Sankyo Co., Ltd. ArQule, Inc. was founded in 1993 and is headquartered in Woburn, Massachusetts.
Advisors' Opinion:- [By Roberto Pedone]
ArQule (ARQL), a clinical-stage biotechnology company, researches and develops cancer therapeutics. This stock closed up 3.4% to $1.49 in Thursday's trading session.
Thursday's Range: $1.44-$1.54
52-Week Range: $1.29-$2.94
Thursday's Volume: 908,000
Three-Month Average Volume: 567,811From a technical perspective, ARQL jumped higher here right above some near-term support at $1.40 with above-average volume. This move briefly pushed shares of ARQL back above its 50-day moving average of $1.53, before the stock closed just below that level at $1.49. This move is starting to push shares of ARQL within range of triggering a near-term breakout trade. That trade will hit if ARQL manages to take out some near-term overhead resistance levels at $1.54 to $1.60 with high volume.
Traders should now look for long-biased trades in ARQL as long as it's trending above some near-term support levels at $1.40 or at $1.35 and then once it sustains a move or close above those breakout levels with volume that hits near or above 567,811 shares. If that breakout hits soon, then ARQL will set up to re-test or possibly take out its next major overhead resistance levels at $1.66 to $1.78, or even $1.90 to $2.
No comments:
Post a Comment